<img alt="" height="1" width="1" />Ironwood $188 Million IPO Raises 30% Less Than SoughtBusinessWeekIronwood, which is developing a treatment for chronic constipation and irritable bowel syndrome, sold 16.7 million Class A shares at $11.25 each, ...<nobr></nobr> |